+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-09-08Number of Pages: 154

Radiodermatitis Market (Product type - Topical (Corticosteroids, Hydrophilic Creams, and Topical Antibiotics), Oral Medication (Corticosteroids, Oral Analgesics, Antibiotics), and Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing (GM-CSF Gauze and Silver Leaf Dressing); By Distribution Channel - Hospital Pharmacy, Retail Pharmacy Store, and Online Store) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Radiodermatitis Market

Chapter 4. Market Overview
4.1. Introduction
4.2. Market Dynamics
      4.2.1. Drivers
      4.2.2. Restraints
      4.2.3. Opportunity
4.3. Value Chain Analysis

Chapter 5. Global Radiodermatitis Market Analysis and Forecast, by Product
5.1. Key Findings
5.2. Introduction
5.3. Market Size (US$ Mn) Forecast, by Product
      5.3.1. Topical
               5.3.1.1. Corticosteroids
               5.3.1.2. Hydrophilic Creams
               5.3.1.3. Others (topical antibiotics)
      5.3.2. Oral Medication
               5.3.2.1. Corticosteroids
               5.3.2.2. Others (analgesics, antibiotics, etc.)
      5.3.3. Dressings
               5.3.3.1. Hydrogel
               5.3.3.2. Hydrocolloid
               5.3.3.3. No Sting Barrier Film
               5.3.3.4. Honey Impregnated Gauze
               5.3.3.5. Silicone Coated Dressing
               5.3.3.6. Others (silver leaf dressings, GM-CSF gauze, etc.)
5.4. Market Attractiveness Analysis, by Product, 2015
5.5. Key Trends

Chapter 6. Global Radiodermatitis Market Analysis and Forecast, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Distribution Channel
      6.3.1. Hospital Pharmacy
      6.3.2. Retail Pharmacy Store 
      6.3.3. Online Store
6.4. Market Attractiveness Analysis, by Distribution Channel, 2015

Chapter 7. Pipeline Analysis
7.1. List of discontinued trials
7.2. Clinical trial data for open studies

Chapter 8. Global Radiodermatitis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Region
      8.3.1. North America
      8.3.2. Europe
      8.3.3. Asia Pacific
      8.3.4. Latin America
      8.3.5. Middle East & Africa
8.4. Market Attractiveness Analysis, by Region, 2015
8.5. Key Trends

Chapter 9. North America Radiodermatitis Market Analysis and Forecast
9.1. Key Findings
9.2. Introduction
9.3. Market Size (US$ Mn) Forecast, by Product 
      9.3.1. Topical
      9.3.2. Oral Medication
      9.3.3. Dressings
9.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      9.4.1. Hospital Pharmacy
      9.4.2. Retail Pharmacy Store
      9.4.3. Online Store
9.5. Market Size (US$ Mn) Forecast, by Country
      9.5.1. U.S.
      9.5.2. Canada
9.6. Market Attractiveness Analysis, by Product, 2015
9.7. Market Attractiveness Analysis, by Distribution Channel, 2015
9.8. Key Trends

Chapter 10. Europe Radiodermatitis Market Analysis and Forecast
10.1. Key Findings
10.2. Introduction
10.3. Market Size (US$ Mn) Forecast, by Product 
      10.3.1. Topical
      10.3.2. Oral Medication
      10.3.3. Dressings
10.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      10.4.1. Hospital Pharmacy
      10.4.2. Retail Pharmacy Store
      10.4.3. Online Store
10.5. Market Size (US$ Mn) Forecast, by Country
      10.5.1. U.K.
      10.5.2. Germany
      10.5.3. Rest of Europe
10.6. Market Attractiveness Analysis, by Product, 2015 
10.7. Market Attractiveness Analysis, by Distribution Channel, 2015
10.8. Key Trends

Chapter 11. Asia Pacific Radiodermatitis Market Analysis and Forecast
11.1. Key Findings
11.2. Introduction
11.3. Market Size (US$ Mn) Forecast, by Product 
      11.3.1. Topical
      11.3.2. Oral Medication
      11.3.3. Dressings
11.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      11.4.1. Hospital Pharmacy
      11.4.2. Retail Pharmacy Store
      11.4.3. Online Store
11.5. Market Size (US$ Mn) Forecast, by Country
      11.5.1. China
      11.5.2. Japan
      11.5.3. Rest of Asia Pacific
11.6. Market Attractiveness Analysis, by Product, 2015 
11.7. Market Attractiveness Analysis, by Distribution Channel, 2015
11.8. Key Trends

Chapter 12. Latin America Radiodermatitis Market Analysis and Forecast
12.1. Key Findings
12.2. Introduction
12.3. Market Size (US$ Mn) Forecast, by Product 
      12.3.1. Topical
      12.3.2. Oral Medication
      12.3.3. Dressings
12.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      12.4.1. Hospital Pharmacy
      12.4.2. Retail Pharmacy Store
      12.4.3. Online Store
12.5. Market Size (US$ Mn) Forecast, by Country
      12.5.1. Brazil
      12.5.2. Mexico
      12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis, by Product, 2015 
12.7. Market Attractiveness Analysis, by Distribution Channel, 2015
12.8. Key Trends

Chapter 13. Middle East & Africa Radiodermatitis Market Analysis and Forecast
13.1. Key Findings
13.2. Introduction
13.3. Market Size (US$ Mn) Forecast, by Product 
      13.3.1. Topical
      13.3.2. Oral Medication
      13.3.3. Dressings
13.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      13.4.1. Hospital Pharmacy
      13.4.2. Retail Pharmacy Store
      13.4.3. Online Store
13.5. Market Size (US$ Mn) Forecast, by Country
      13.5.1. UAE
      13.5.2. South Africa
      13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis, by Product, 2015 
13.7. Market Attractiveness Analysis, by Distribution Channel, 2015
13.8. Key Trends

Chapter 14. Competition Landscape
14.1. Market Share Analysis
14.2. Competition Matrix
14.3. Company Profiles
      14.3.1. 3M 
               14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
               14.3.1.2. Financial Overview
               14.3.1.3. Product Portfolio
               14.3.1.4. SWOT Analysis
               14.3.1.5. Strategic Overview
      14.3.2. Acelity LP, Inc.
               14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
               14.3.2.2. Financial Overview
               14.3.2.3. Product Portfolio
               14.3.2.4. SWOT Analysis
               14.3.2.5. Strategic Overview
      14.3.3. BMG Pharma S.r.l.
               14.3.3.1. Company Overview (HQ, business segments, employee strength)
               14.3.3.2. Product Portfolio
               14.3.3.3. SWOT Analysis
               14.3.3.4. Recent Developments
               14.3.3.5. Strategic Overview
      14.3.4. ConvaTec, Inc.
               14.3.4.1. Company Overview (HQ, business segments, employee strength)
               14.3.4.2. Financial Overview
               14.3.4.3. Product Portfolio
               14.3.4.4. SWOT Analysis
               14.3.4.5. Strategic Overview
      14.3.5. Derma Sciences Inc.
               14.3.5.1. Company Overview (HQ, business segments, employee strength)
               14.3.5.2. Financial Overview
               14.3.5.3. Product Portfolio
               14.3.5.4. SWOT Analysis
               14.3.5.5. Strategic Overview
      14.3.6. Intermed Pharmaceuticals
               14.3.6.1. Company Overview (HQ, business segments, employee strength)
               14.3.6.2. Product Portfolio
               14.3.6.3. SWOT Analysis
               14.3.6.4. Recent Developments
               14.3.6.5. Strategic Overview
      14.3.7. Molnlycke Health Care
               14.3.7.1. Company Overview (HQ, business segments, employee strength)
               14.3.7.2. Financial Overview
               14.3.7.3. Product Portfolio
               14.3.7.4. SWOT Analysis
               14.3.7.5. Strategic Overview
      14.3.8. Smith & Nephew plc
               14.3.8.1. Company Overview (HQ, business segments, employee strength)
               14.3.8.2. Financial Overview
               14.3.8.3. Product Portfolio
               14.3.8.4. SWOT Analysis
               14.3.8.5. Strategic Overview
      14.3.9. Stratpharma AG
               14.3.9.1. Company Overview (HQ, business segments, employee strength)
               14.3.9.2. Product Portfolio
               14.3.9.3. SWOT Analysis
               14.3.9.4. Strategic Overview
               14.3.9.5. Value Chain
      14.3.10. Others

List of Figures

Figure 1: Global Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 2: Global Radiodermatitis Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 3: Global Topical Products Market Revenue (US$ Mn), 2014–2024
Figure 4: Global Oral Medication Market Revenue (US$ Mn), 2014–2024
Figure 5: Global Dressings Market Revenue (US$ Mn), 2014–2024
Figure 6: Global Topical Corticosteroids Market Revenue (US$ Mn), 2014–2024
Figure 7: Global Hydrophilic Creams Market Revenue (US$ Mn), 2014–2024
Figure 8: Global Other Topical agents Market Revenue (US$ Mn), 2014–2024
Figure 9: Global Oral Analgesic, Anti-inflammatory & Antibiotic Market Revenue (US$ Mn), 2014-2024
Figure 10: Global Oral Corticosteroids Market Revenue (US$ Mn), 2014–2024
Figure 11: Global Hydrogel Market Revenue (US$ Mn), 2014–2024
Figure 12: Global Hydrocolloid Market Revenue (US$ Mn), 2014–2024
Figure 13: Global No Sting Barrier Film Market Revenue (US$ Mn), 2014–2024
Figure 14: Global Honey Impregnated Gauze Market Revenue (US$ Mn), 2014–2024
Figure 15: Global Silicone Coated Dressing Market Revenue (US$ Mn), 2014–2024
Figure 16: Global Other Dressings Market Revenue (US$ Mn), 2014–2024
Figure 17: Radiodermatitis Market Attractiveness Analysis, by Product Type
Figure 18: Global Radiodermatitis Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 19: Global Hospital Pharmacy Market Revenue (US$ Mn), 2014–2024
Figure 20: Global Retail Pharmacy Store Market Revenue (US$ Mn), 2014–2024
Figure 21: Global Online Store Market Revenue (US$ Mn), 2014–2024
Figure 22: Radiodermatitis Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 23: Global Radiodermatitis Market Value Share Analysis, by Region, 2015 and 2024
Figure 24: Radiodermatitis Market Attractiveness Analysis, by Region, 2015
Figure 25: North America Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 26: North America Market Attractiveness Analysis, by Country, 2015
Figure 27: North America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 28: North America Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 29: North America Market Value Share Analysis, by Country, 2015 and 2024
Figure 30: North America Market Attractiveness Analysis, by Product Type, 2015
Figure 31: North America Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 32: Europe Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 33: Europe Market Attractiveness Analysis, by Country, 2015
Figure 34: Europe Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 35: Europe Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 36: Europe Market Value Share Analysis, by Country, 2015 and 2024
Figure 37: Europe Market Attractiveness Analysis, by Product Type, 2015
Figure 38: Europe Market Attractiveness Analysis, by Distribution Channel, 2015 
Figure 39: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 40: Asia Pacific Market Attractiveness Analysis, by Country, 2015
Figure 41: Asia Pacific Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 42: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 43: Asia Pacific Market Value Share Analysis, by Country, 2015 and 2024
Figure 44: Asia Pacific Market Attractiveness Analysis, by Product Type, 2015
Figure 45: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 46: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 47: Latin America Market Attractiveness Analysis, by Country, 2015
Figure 48: Latin America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 49: Latin America Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 50: Latin America Market Value Share Analysis, by Country, 2015 and 2024
Figure 51: Latin America Market Attractiveness Analysis, by Product Type, 2015
Figure 52: Latin America Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 53: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 54: Middle East & Africa Market Attractiveness Analysis, by Country, 2015
Figure 55: Middle East & Africa Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 56: Middle East & Africa Market Value Share Analysis by Distribution Channel, 2015 and 2024
Figure 57: Middle East & Africa Market Value Share Analysis, by Country, 2015 and 2024
Figure 58: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2015
Figure 59: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 60: Global Radiodermatitis Market Share Analysis by Company (2015)

List of Tables

Table 1: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 3: List of Discontinued Clinical Trials
Table 4: List of Open Clinical Trials
Table 5: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 6: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 7: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 8: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 9: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 11: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 12: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 13: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 14: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 15: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 16: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 17: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 18: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 19: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 20: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024


 
 
Back To Top